TRAX
NASDAQ HealthcareFirst Tracks Biotherapeutics, Inc. - Ordinary Shares
Biotechnology
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
๐ Market Data
| Price | $22.38 |
|---|---|
| Volume | 593,932 |
| Market Cap | 777.68M |
| RSI (14-Day) | 46.5 |
| 52-Week High | $26.80 |
| 52-Week Low | $14.79 |
| Forward P/E | -6.87 |
๐ฏ Investment Strategy Scores
TRAX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (66/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Moon Shot (15/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Find TRAX in your text
Paste any article, transcript, or post โ the tool will extract TRAX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.